Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2009 1
2010 4
2011 2
2012 2
2013 2
2014 1
2017 1
2018 3
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Adherence and patients' experiences with the use of oral anticancer agents.
Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG. Timmers L, et al. Among authors: timmer bonte jn. Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22. Acta Oncol. 2014. PMID: 24266637
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.
van den Berg MMGA, Kok DE, Posthuma L, Kamps L, Kelfkens CS, Buist N, Geenen M, Haringhuizen A, Heijns JB, van Lieshout RHMA, Los M, Sommeijer DW, Timmer-Bonte JNH, de Kruif ATCM, van Laarhoven HWM, Kampman E, Winkels RM. van den Berg MMGA, et al. Among authors: timmer bonte jnh. Breast Cancer Res Treat. 2019 Jan;173(2):475-481. doi: 10.1007/s10549-018-5014-5. Epub 2018 Oct 23. Breast Cancer Res Treat. 2019. PMID: 30353244 Free PMC article.
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
van Steenhoven JEC, Kuijer A, van Diest PJ, van Gorp JM, Straver M, Elias SG, Wesseling J, Rutgers E, Timmer-Bonte JNH, Nieboer P, Smilde TJ, Imholz A, Blanken CFJM, Siesling S, van Dalen T. van Steenhoven JEC, et al. Among authors: timmer bonte jnh. Genes (Basel). 2018 May 17;9(5):261. doi: 10.3390/genes9050261. Genes (Basel). 2018. PMID: 29772837 Free PMC article.
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
de Geus-Oei LF, van der Heijden HF, Visser EP, Hermsen R, van Hoorn BA, Timmer-Bonte JN, Willemsen AT, Pruim J, Corstens FH, Krabbe PF, Oyen WJ. de Geus-Oei LF, et al. Among authors: timmer bonte jn. J Nucl Med. 2007 Oct;48(10):1592-8. doi: 10.2967/jnumed.107.043414. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873138 Free article. Clinical Trial.
17 results